Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tao Qing

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Cell Death & Disease|May 18, 2023
Identification of RAC1 in promoting brain metastasis of lung adenocarcinoma using single-cell transcriptome sequencingMingyu Chen, Hanyue Li, Xiaolin Xu, et al.
Cancer Research|March 5, 2022
Comprehensive Analysis of Metabolic Isozyme Targets in CancerMichal Marczyk, Vignesh Gunasekharan, David Casadevall, et al.
NPJ Breast Cancer|February 4, 2022
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancerJulia Foldi, Andrea Silber, Emily Reisenbichler, et al.
NPJ Breast Cancer|February 9, 2021
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancerJulia Foldi, Andrea Silber, Emily Reisenbichler, et al.
Breast Cancer Research : BCR|May 2, 2021
Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer patientYuanting Zheng, Bingying Li, Dejing Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2022
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast CancerKim R M Blenman, Michal Marczyk, Thomas Karn, et al.
Gastrointestinal Endoscopy|December 1, 2016
Comparison of endoscopic submucosal tunneling dissection and thoracoscopic enucleation for the treatment of esophageal submucosal tumorsQing-Yuan Li, Yan Meng, Yu-Yuan Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2021
Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast CancerIoannis A Vathiotis, Myrto K Moutafi, Prajan Divakar, et al.
Nature Communications|February 11, 2014
A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stagesYing Yu, James C Fuscoe, Chen Zhao, et al.
Nature Biotechnology|September 7, 2023
Quartet RNA reference materials improve the quality of transcriptomic data through ratio-based profilingYing Yu, Wanwan Hou, Yaqing Liu, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cell Death & Disease|May 18, 2023
Identification of RAC1 in promoting brain metastasis of lung adenocarcinoma using single-cell transcriptome sequencingMingyu Chen, Hanyue Li, Xiaolin Xu, et al.
Cancer Research|March 5, 2022
Comprehensive Analysis of Metabolic Isozyme Targets in CancerMichal Marczyk, Vignesh Gunasekharan, David Casadevall, et al.
NPJ Breast Cancer|February 4, 2022
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancerJulia Foldi, Andrea Silber, Emily Reisenbichler, et al.
NPJ Breast Cancer|February 9, 2021
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancerJulia Foldi, Andrea Silber, Emily Reisenbichler, et al.
Breast Cancer Research : BCR|May 2, 2021
Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer patientYuanting Zheng, Bingying Li, Dejing Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2022
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast CancerKim R M Blenman, Michal Marczyk, Thomas Karn, et al.
Gastrointestinal Endoscopy|December 1, 2016
Comparison of endoscopic submucosal tunneling dissection and thoracoscopic enucleation for the treatment of esophageal submucosal tumorsQing-Yuan Li, Yan Meng, Yu-Yuan Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2021
Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast CancerIoannis A Vathiotis, Myrto K Moutafi, Prajan Divakar, et al.
Nature Communications|February 11, 2014
A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stagesYing Yu, James C Fuscoe, Chen Zhao, et al.
Nature Biotechnology|September 7, 2023
Quartet RNA reference materials improve the quality of transcriptomic data through ratio-based profilingYing Yu, Wanwan Hou, Yaqing Liu, et al.
Pageof 8